Zurbriggen; Rinaldo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zurbriggen; Rinaldo.The latest application filed is for "truncated secretory aspartyl proteinase 2".

Company Profile

0.14.16

Zurbriggen; Rinaldo - Schmitten CH
Zurbriggen; Rinaldo - Rainstrasse N/A CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Truncated secretory aspartyl proteinase 2 Grant 9,610,334 - Zurbriggen , et al. April 4, 2	2017-04-04
Virosome-like vesicles comprising gp41-derived antigens Grant 9,216,156 - Fleury , et al. December 22, 2	2015-12-22
Multiepitope vaccine for Her2/neu-associated cancers Grant 8,852,604 - Kammer , et al. October 7, 2	2014-10-07
Truncated Secretory Aspartyl Proteinase 2 App 20140193445 - Zurbriggen; Rinaldo ; et al.	2014-07-10
Truncated secretory aspartyl proteinase 2 Grant 8,715,698 - Zurbriggen , et al. May 6, 2	2014-05-06
Lyophilization of Virosomes App 20140072616 - Zurbriggen; Rinaldo ; et al.	2014-03-13
Trans-adjuvant system Grant 8,496,962 - Zurbriggen , et al. July 30, 2	2013-07-30
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof Grant 8,367,077 - Zurbriggen , et al. February 5, 2	2013-02-05
Multiepitope Vaccine for Her2/Neu-Associated Cancers App 20120195962 - Kammer; Andreas ; et al.	2012-08-02
Non-Specific Immunostimulating Agents App 20120164181 - Moser; Christian ; et al.	2012-06-28
Non-specific Immunostimulating Agents App 20110142912 - Moser; Christian ; et al.	2011-06-16
Virosomes Comprising Hemagglutinin Derived from an Influenza Virus Produced in a Cell Line, Compositions, Methods of Manufacturing, Use Thereof App 20110045057 - Zurbriggen; Rinaldo ; et al.	2011-02-24
Method For Synthesizing Conformationally Constrained Peptides, Peptidomimetics And The Use Thereof As Synthetic Vaccines App 20110008414 - Pluschke; Gerd ; et al.	2011-01-13
Truncated Secretory Aspartyl Proteinase 2 App 20100285109 - Zurbriggen; Rinaldo ; et al.	2010-11-11
Novel Trans-Adjuvant System App 20100015214 - Zurbriggen; Rinaldo ; et al.	2010-01-21
Method For Synthesizing Conformationally Constrained Peptides, Peptidomimetics And The Use Thereof As Synthetic Vaccines App 20090324707 - Pluschke; Gerd ; et al.	2009-12-31
Virosome-like Vesicles Comprising Gp41-derived Antigens App 20090202622 - Fleury; Sylvain ; et al.	2009-08-13
Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines Grant 7,569,541 - Pluschke , et al. August 4, 2	2009-08-04
Lyophilization of virosomes App 20080268028 - Zurbriggen; Rinaldo ; et al.	2008-10-30
Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide App 20080107649 - Zurbriggen; Rinaldo	2008-05-08
High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them Grant 7,329,807 - Vadrucci , et al. February 12, 2	2008-02-12
Compositions and methods for the generation of protective immune responses against malaria Grant 7,198,791 - Pluschke , et al. April 3, 2	2007-04-03
Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines App 20060258564 - Pluschke; Gerd ; et al.	2006-11-16
Compositions and methods for the generation of protective immune responses against malaria App 20040175392 - Pluschke, Gerd ; et al.	2004-09-09
Methods and compositions for the design of synthetic vaccines App 20040176283 - Robinson, John A. ; et al.	2004-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.